Addiction Science & Clinical Practice is pleased to announce an upcoming special series on the opioid use disorder (OUD) care continuum, specifically articles describing broad research and data supported by the National Drug Abuse Treatment Clinical Trials Network (CTN): its past effort in developing MOUD treatment and current effort in improving MOUD treatment quality. The series will commemorate 20 years of CTN research activities are be guest edited by:
E. Jennifer Edelman, MD, MHS, Yale University, USA
Andrew J. Saxon, MD, University of Washington, USA
This thematic series will highlight in an open-access format articles focusing on identification of OUD, access and linkage to care, medication and other treatment initiation, treatment retention (including tools that promote retention in care via technology, contingency management, etc.), research-practice gaps, and quality of care, as well as the impact of COVID-19 on the OUD care continuum. The series will welcome all manuscript submissions on these topics (including study protocols) from CTN-supported researchers and those who work with CTN-supported data.
ASCP is an open-access, Medline and PsycINFO-listed journal. It provides a forum for clinically relevant research and perspectives that contribute to improving the quality of care for people with unhealthy alcohol, tobacco, or other drug use and addictive behaviors across a spectrum of clinical settings. It is published by BMC, part of Springer Nature and a leader in the field of open-access publishing.
CTN was established by the National Institute on Drug Abuse (NIDA) to bridge the gap between substance use disorder research and clinical practice.
Funding for the article-processing charge is available thanks to the generosity of NIDA CTN. This is subject to editorial acceptance and will be offered while funds are available. All submissions to ASCP are subject to editorial and peer review.
CTN policy requires papers to be reviewed in the CTN Publications Committee (PC), prior to being submitted to ASCP. To participate in the issue, email your manuscript to Jack Blaine (firstname.lastname@example.org) and George Bigelow (email@example.com) with a copy to Udi Ghitza (firstname.lastname@example.org) and Landhing Moran (email@example.com) in the Center for the Clinical Trials Network for review and approval.
Submissions will be reviewed on a rolling basis upon receipt and are requested through the fall of 2020. They should be submitted to the CTN PC prior to this deadline. The original deadline has been extended due to the impact of COVID-19 on research activities. All CTN-approved submissions will be subject to standard peer-review and editorial policies and will be published at the discretion of the Editors-in-Chief. If any guest editors author an article, they will not handle the peer review process.